News

Welcome back Mette Bach Dyremose

Nov 5, 2024

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion’s communication efforts!

With over 20 years of experience in strategic communication, business development, and life sciences, Mette has a unique talent for turning complex scientific insights into compelling, impactful messages. She began her journey with Ferring Pharmaceuticals, where she developed her expertise in event management and translating research into meaningful narratives.

In her previous role with ReproUnion and Medicon Valley Alliance, Mette was instrumental in shaping the ReproUnion brand and building awareness around key initiatives within reproductive health, including the successful launch of RUBIC. Recently, she contributed to the HALRIC Hanseatic Life Science Research Infrastructure Consortium project, establishing its communication strategy and driving engagement across academia, hospitals, and industry.

With her deep insights and strategic vision, Mette’s return marks an exciting new chapter for ReproUnion as we continue to build an innovative reproductive health platform bridging science, technology, and clinical practice. Alongside ReproUnion, Mette will also work with DiaUnion, supporting their communication and public affairs initiatives.

Welcome back, Mette! We look forward to all that’s ahead with you on the team!

MORE NEWS


RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more

Big News from ReproUnion!

We're thrilled to announce that Professor, founder and CEO Yvonne Lundberg Giwercman a dedicated ReproUnion researcher, was selected to present her start-up Dx4Life at the Nordic Life Science Days! She had the honor of presenting in both the Company Presentation...

read more